Tamoxifen for prevention of breast cancer: extended long- term follow-up of the IBIS-I breast cancer prevention trial. Lancet Oncol 2015;16(1):67-75.Cuzick J, Sestak I, Cawthorn S, Hamed H, Holli K, Howell A, et al. Tamoxifen for prevention of breast cancer: extended long-term follow...
Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial. Lancet Oncol 2015; 16(1): 67-75.Cuzick, J., Sestak, I., Cawthorn, S., Hamed, H., Holli, K., Howell, A., & Forbes, J. F. (2015). Tamoxifen for prevention of...
Re: Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study Fisher et al. (1) demonstrate a statistically significant reduction in the incidence of invasive and noninvasive cancers of the breast associated with tamo... S Narod - ...
Errico A. Breast cancer: tamoxifen-offering a long-term prevention option. Nat Rev Clin Oncol 2015; 12:66.Errico A. Breast cancer: Tamoxifen-offering a long-term prevention option. Nat Rev Clin Oncol 2015; 12:66.A. Errico. Tamoxifen虏offering a long-term prevention option. Nature Rev. ...
Response: Re: Tamoxifen for Prevention of Breast Cancer: Reportof the National Surgical Adjuvant Breast and Bowel Project P-1 Study The risk/benefit assessment provided by Dr. Love is inappropriate. First, the population selected (the women in the Breast Cancer Prevention Trial) represe... B Fi...
Graphs to estimate an individualized risk of breast cancer. J Clin Oncol 1996; 14: 103–10. PubMed CAS Google Scholar Fisher B, Constantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J...
The hypothesis that estrogen is an important promoter of carcinogenically induced mammary neoplasia opens up some attractive possibilities for prevention of some, most, or all clinical breast cancers. This chapter will explore the evidence in support of such a hypothesis and examine the logistic ...
Tamoxifen, raloxifene and the prevention of breast cancer. The recognition of a new group of drugs, now named selective estrogen receptor modulators (SERMs) has revolutionized prospects for the prevention of breast... JV Craig,M Monica - 《Endocrine Reviews》 被引量: 789发表: 1999年 High-grade...
Powles TJ. The case for clinical trials of tamoxifen for prevention of breast cancer. Lancet 1992;340:1145-7.Powles TJ.The case for clinical trials of tamoxifen for prevention of breast cancer. The Lancet . 2004Powles, T. J. The case for clinical trials of tamoxifen for prevention of ...
Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. PURPOSE: This is the initial report from the health-related quality of life (HRQL) component of the National Surgical Adjuvant Breast and ...